LINC01296 as a miR-26a direct target through LINC01296/miR-26a/GALNT3 axis encourage CRC malignancy using regulating O-glycosylated MUC1 by PI3K/AKT pathway. Here, GALNT3 is linked to colorectal carcinoma.